Photo of Marshall Posner
Accepting New Patients
Marshall Posner, MD
    • Positions
    • PROFESSOR | Medicine, Hematology and Medical Oncology
    • PROFESSOR | Otolaryngology
    • Specialties
    • Oncology
    • Hematology-Oncology
    • Language
    • English
    • Hospital Affiliation
    • The Mount Sinai Hospital
    • Phone
    • Ruttenberg Treatment Center 212-241-6756
Request an Appointment
1470 Madison Avenue 3rd floor
New York, NY 10029
Phone: 212-241-6756

Dr. Marshall Posner is a Professor of Medicine, Medical Director of the Head and Neck Oncology Center, and Associate Director of the Center for Personalized Cancer Therapeutics at the Mount Sinai Medical Center and the Icahn School of Medicine at Mount Sinai. He is also Associate Director for Cancer Clinical Research Infrastructure for the Tisch Cancer Institute.  Dr. Posner has been an advocate for clinical research and multi-disciplinary care in head and neck cancer. He participates in international symposia and on planning committees devoted to advancing clinical care and directing clinical research in head and neck cancer.
He is a current or past member of the editorial boards of many journals, including the Journal of Clinical Oncology, Annals of Oncology, Oral Oncology, The Oncologist, and Head and Neck, and he serves as an ad hoc reviewer for, among others, The New England Journal of Medicine. Dr. Posner has been a member of the National Institutes of Health Review Committees for the NIH Inter-Institute Program and the Specialized Programs of Research Excellence in Human Cancer, Head & Neck Cancer, and of the National Cancer Institute's Special Emphasis Panel for phase II Contracts. He has published over 220 peer-reviewed basic laboratory and clinical studies, as well as multiple reviews and abstracts. He is an Section Editor for UpToDate and the Oncologist.

Dr. Posner has a long laboratory and translational research history in viral diseases and immunology and is currently leading research in the biology, immunology and therapy of HPV related oropharyngeal cancer. he holds patents in human monoclonal antibodies for treatment of human viral and bacterial related diseases.

In the News:
Dr. Posner discusses HPV-related oral cancer in the New York Times.

Dr. Posner discusses the warning signs of oral cancer and what to watch out for on the Katie Couric show.

The ASCO Post features Dr. Posner discussing "Challenges, Progress, and Future Directions in Head and Neck Cancer" (March 1, 2012)

Dr. Marshall Posner discusses the link between HPV and oropharyngeal cancers in The Daily News feature The Daily Check Up.


Medical Oncology
American Board of Internal Medicine

Clinical Focus

  • Adenoid Cystic Carcinoma (ACC)
  • Cancer Prevention
  • Cancer Survivorship
  • Clinical Trials
  • Gum Cancer
  • Head and Neck Cancers
  • Immunotherapy
  • Merkel Cell Tumors
  • Mouth Cancer
  • Nasal Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer (NPC)
  • Oral Cavity Cancer
  • Oropharynx Cancer
  • Paranasal Sinus Cancer
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pharynx Cancer
  • Photodynamic Therapy
  • Salivary Gland Tumors
  • Sinus Cancer
  • Skull Base Tumors
  • Squamous Cell Carcinoma
  • Throat Cancer
  • Thyroid Cancer
  • Thyroid Tumors
  • Tonsil Cancer
  • Vaccines

Research Topics

AIDS/HIV, Anti-Tumor Therapy, Cellular Immunity, Immunology, Tumorigenesis, Viruses and Virology


MD, Tufts University School of Medicine

Residency, Internal Medicine
Boston City Hospital

Fellowship, Medical Oncology
Dana Farber Cancer Institute